BETH ISRAEL DEACONESS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $168.2M
- Transactions
- 7,154
- Companies
- 40
- Average per transaction
- $23,506
Who reported the payments
| Janssen Research & Development, LLC | $17,771,529 |
| CSL Behring | $15,578,548 |
| Pfizer | $12,045,530 |
| GE HealthCare | $11,572,523 |
| Gilead | $10,945,468 |
| Johnson & Johnson | $10,614,543 |
| Vertex | $9,886,349 |
| Merck | $7,931,039 |
| AbbVie | $4,455,681 |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,209,706 |
| Philips North America LLC | $4,080,495 |
| Boston Scientific | $2,716,291 |
| AstraZeneca | $2,291,231 |
| Biogen | $2,201,668 |
| Alkermes, Inc. | $1,968,405 |
| Medtronic | $1,955,704 |
| Regeneron | $1,948,412 |
| Genentech, Inc. | $1,821,636 |
| Bristol Myers Squibb | $1,812,822 |
| Abbott | $1,761,915 |
| Incyte Corporation | $1,642,251 |
| Amgen | $1,618,845 |
| E.r. Squibb & Sons, L.L.C. | $1,517,097 |
| Brahms GmbH | $1,352,366 |
| Edwards Lifesciences | $1,282,954 |
| Seagen Inc. | $1,241,666 |
| Sanofi US Services Inc. | $1,157,426 |
| Roche TCRC, Inc. | $1,016,954 |
| Boehringer Ingelheim | $1,000,659 |
| Sirtex Medical Inc | $757,411 |
| Alcresta Therapeutics, Inc. | $736,202 |
| Novartis | $649,973 |
| EMD Serono, Inc. | $644,769 |
| UCB SA | $601,916 |
| Bard Peripheral Vascular, Inc. | $595,103 |
| Beckman Coulter, Inc. | $590,656 |
| Cook Research Incorporated | $564,281 |
| Genmab U.S., Inc. | $517,903 |
| Eli Lilly | $510,958 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $503,847 |